Z5S-35196-88279 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-20
Dose 1 — Pfizer-BioNTech
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-12-20
Registered in v-safe
2021-12-20
Dose 3 — Pfizer-BioNTech
2021-12-20
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tiredness

Adult check-in
2021-12-21
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-12-22
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Lymphadenopathy, Tenderness — Feeling: Good

Free text: Injection side axillary pain/tender lymphadenopathy

MedDRA releases: 2024-11 · check-in free text available
2021-12-23
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy, Tenderness — Feeling: Good

Free text: Mild axillary lymphadenopathy, tenderness

MedDRA releases: 2024-11 · check-in free text available
2021-12-24
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-25
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Nausea · Be unable to do your normal daily activities

Adult check-in
2021-12-26
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-27
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-03
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-10
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-01-17
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-01-24
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-31
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-03-21
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-06-21
Survey response — 6 months, dose 3
MedDRA: Gestational hypertension, Pre-eclampsia — Feeling: Good · Get care from a doctor or other healthcare professional · Hospitalization

Free text: Preeclampsia, gestational hypertension

MedDRA releases: 2024-11 · check-in free text available
2022-06-21
Report sent to call center — 6 months, dose 3
Get care from a doctor or other healthcare professional

Hospitalization · 1 call case(s)
2022-06-22
Call 1 — Left Voicemail
2022-12-20
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-20	Pfizer-BioNTech	No
2	2021-01-11	Pfizer-BioNTech	No
3	2021-12-20	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-06-21	Unsuccessful

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-22

Systemic reaction (other): Injection side axillary pain/tender lymphadenopathy

2021-12-23

Systemic reaction (other): Mild axillary lymphadenopathy, tenderness

Release 12 — 6 months, dose 3

2022-06-21

Symptoms: Preeclampsia, gestational hypertension

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Gestational hypertension	·	·	✓
SD	Pre-eclampsia	·	·	✓
SRO	Axillary pain	·	·	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Tenderness	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release